Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis

被引：0
|
作者：
Arents, Bernd W. M. [1 ]
机构：
[1] Dutch Assoc People Atop Dermatitis, Nijkerk, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷 / 06期
关键词：
D O I：
10.1093/bjd/ljad068
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：694 / 694
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
    Paller, Amy
    Flohr, Carsten
    Eichenfield, Lawrence F.
    Irvine, Alan
    Correia, Ana Pinto
    Natalie, Chitra R.
    Pierce, Evangeline
    Lima, Renata Gontijo
    Laquer, Vivian
    Weidinger, Stephan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB84 - AB84
  • [22] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
    Linda Stein Gold
    Diamant Thaçi
    Jacob P. Thyssen
    Melinda Gooderham
    Vivian Laquer
    Angela Moore
    Chitra R. Natalie
    Fangyi Zhao
    Eric Meskimen
    Hany Elmaraghy
    Sonia Montmayeur
    Gaia Gallo
    Gemma Jimenez
    Marjolein de Bruin-Weller
    American Journal of Clinical Dermatology, 2023, 24 : 595 - 607
  • [23] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kraft, Magdalena
    Worm, Margitta
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
  • [24] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    James E. Frampton
    Hannah A. Blair
    American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
  • [25] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    Frampton, James E.
    Blair, Hannah A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (04) : 617 - 624
  • [26] LEBRIKIZUMAB MONOTHERAPY REDUCES FLARES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
    Del Rosso, James Q.
    Kwong, Pearl
    Hussain, Iftikhar
    Barbarot, Sebastien
    Manuel Carrascosa, Jose
    Rueda, Maria Jose
    Atwater, Amber Reck
    Elmaraghy, Hany
    Sun, Luna
    Chen, Sherry
    Natalie, Chitra R.
    Weidinger, Stephan
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 32 - 32
  • [27] Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Villegas, Susan C.
    Dima, Lorena
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (02) : E117 - E125
  • [28] An evaluation of abrocitinib for moderate-to-severe atopic dermatitis
    Labib, Angelina
    Yosipovitch, Gil
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (11) : 1107 - 1118
  • [29] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
    Devjani, Shivali
    Engel, Priya, V
    Javadi, Sogol S.
    Smith, Brandon
    Wu, Jashin J.
    LANCET, 2023, 402 (10415): : 1833 - 1834
  • [30] Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
    Silverberg, Jonathan I.
    Bieber, Thomas
    Paller, Amy S.
    Beck, Lisa
    Kamata, Masahiro
    Puig, Luis
    Wiseman, Marni
    Ezzedine, Khaled
    Irvine, Alan D.
    Foley, Peter
    Del Rosso, James
    Gold, Linda Stein
    Johansson, Erin
    Dossenbach, Martin
    Gallo, Gaia
    Akmaz, Buelent
    Casillas, Marta
    Karlsson, Andrei
    Curteis, Tristan
    Chovatiya, Raj
    DERMATOLOGY AND THERAPY, 2025, 15 (03) : 615 - 633
12345